Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Using Index Funds In Retirement Portfolios discusses straightforward methods to blend broad-market index funds into retirement allocations.
18,590 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
US stocks closed higher on Friday as a wave of fresh analyst calls lifted growth names such as Best Buy, Dell Technol...
After blue origin rocket blast, NASA's lunar schedule tilts toward SpaceX, while investors watch a forthcoming SpaceX...
Lenders push automation and AI in a bid to speed closings, but costs rise and internal handoffs persist. Analysts wei...
Bitcoin led a broad retreat as the crypto market shed about $140B in value over 24 hours, pushing total capitalizatio...
As Anthropic prepares an IPO, history warns that sky-high private valuations rarely translate into smooth public-mark...
WPP’s top creative executive warns that human creativity under fire as AI tools accelerate outputs and squeeze budget...
OpenAI and SpaceX confront a profitability horizon that stretches into the 2030s. The classic Good Money framework as...
A provocative forecast from Elon Musk about AI-driven code creation is sending ripples through tech equities and hiri...
June data show existing home sales beat forecasts, signaling ongoing demand strength in 2026. The numbers point to st...
A small group of everyday investors rode space-data trends to multimillion-dollar gains years before a SpaceX IPO hea...
As self-driving tech moves from labs to city streets, control of the platform becomes the real battleground. This art...